161 filings
Page 4 of 9
6-K
pjcdv1h31 6gos
16 Dec 22
AnPac Bio Reports 48.8% Decrease in Net Loss in First Half of 2022
5:01pm
6-K
z9t a6lvdtpx4ei7b15
30 Nov 22
AnPac Announces regaining Compliance with Nasdaq Listing Requirement
5:00pm
6-K
sqk8dq2xxi
10 Nov 22
AnPac Bio Announces Changes to the Board of Directors
5:00pm
6-K
spzpvnmtfx ox3m
4 Nov 22
Current report (foreign)
7:45am
F-6 POS
n6c4hlng5
24 Oct 22
Automatic registration for ADRs (post-effective amendment, foreign)
2:04pm
6-K
98v qjraj
18 Oct 22
AnPac Bio Announces Plan to Implement ADS Ratio Change
6:02am
6-K
0su ylhdvnh
17 Oct 22
Current report (foreign)
5:21pm
6-K
cos1x
3 Oct 22
AnPac Bio Announces Board and Management Changes
6:07am
6-K
whonts x1iqxv
3 Oct 22
Current report (foreign)
6:03am
6-K
mkb5 0q46g0zk31she6c
27 Sep 22
Current report (foreign)
6:03am
6-K
n0binv
20 Sep 22
Current report (foreign)
4:30pm
6-K
57nk10yem6g3gojy 0yn
13 Sep 22
AnPac Bio-Medical Sciences Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Appeal
4:30pm
6-K
an02ilk
5 Aug 22
AnPac Bio Announces Appointment of New Directors and Co-Chief Executive Officer
4:35pm
6-K
c2vaqnmcrz
18 Jul 22
Current report (foreign)
5:00pm
6-K
ew0byt26
21 Jun 22
Current report (foreign)
6:05am
D
gx8ysi5
13 Jun 22
$1.5M in equity / options / securities to be acquired, sold $1.5M, 1 investor
6:06am
D
4dr2ex4pn
13 Jun 22
$1.5M in equity / options / securities to be acquired, sold $1.5M, 1 investor
6:04am
S-8
vfiwp5cq1ag23n2zzqnu
3 Jun 22
Registration of securities for employees
4:32pm
6-K
9bbzszq
31 May 22
AnPac Bio Reports 49.1% Decrease in Net Loss in First Quarter of Fiscal 2022
5:10pm
D
iuxjdau5
27 May 22
$1.4M in equity / options / securities to be acquired, sold $1.4M, 1 investor
4:45pm